1. Home
  2. MDGL

as 09-15-2025 10:32am EST

$
-
-
-
.
-
-
-
$
-
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

Founded: 2011 Country:
United States
United States
Employees: N/A City: WEST CONSHOHOCKEN
Market Cap: 6.1B IPO Year: N/A
Target Price: $474.67 AVG Volume (30 days): 383.6K
Analyst Decision: Strong Buy Number of Analysts: 10
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -12.82 EPS Growth: N/A
52 Week Low/High: $200.63 - $457.16 Next Earning Date: 10-30-2025
Revenue: $515,547,000 Revenue Growth: 3421.98%
Revenue Growth (this year): 394.12% Revenue Growth (next year): 57.74%

MDGL Daily Stock ML Predictions

Stock Insider Trading Activity of Madrigal Pharmaceuticals Inc. (MDGL)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Sibold William John MDGL President and CEO Sep 9 '25 Sell $445.63 7,279 $3,243,740.77 102,474
Sibold William John MDGL President and CEO Aug 21 '25 Sell $400.52 7,616 $3,047,756.37 102,474
BAKER BROS. ADVISORS LP MDGL N/A Aug 20 '25 Buy $384.95 59,901 $23,071,366.47 1,913,699
BAKER BROS. ADVISORS LP MDGL N/A Aug 18 '25 Buy $364.61 105,782 $38,849,657.82 1,913,699
Kelley Shannon T MDGL General Counsel Aug 18 '25 Sell $371.08 1,304 $479,626.86 9,809
BATE KENNETH MDGL N/A Aug 15 '25 Sell $365.88 10,000 $3,652,008.56 4,627
FRIEDMAN PAUL A MDGL N/A Aug 13 '25 Sell $366.29 129,172 $47,825,149.36 307,935
Taub Rebecca MDGL N/A Aug 12 '25 Sell $355.31 43,263 $15,388,278.50 492,095
FRIEDMAN PAUL A MDGL N/A Aug 12 '25 Sell $355.37 43,605 $15,509,469.03 307,935
Taub Rebecca MDGL N/A Aug 11 '25 Sell $350.60 3,200 $1,120,753.15 492,095

Share on Social Networks: